company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,225909000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-88453000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-4081000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-329593000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,1190000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,210847000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-6422000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q4,2010-10-01,2010-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-216512000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-216512000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-211546000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,424633000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,12730000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2928000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,228745000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,228745000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,18471000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q4,2010-10-01,2010-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,256613000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q4,2010-10-01,2010-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-55502000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,40022000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,40022000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,29628000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,56413000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-15764000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,110299000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,110299000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-24748000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-40000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-151149000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,91000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,96720000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-1657000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-80783000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-80783000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-605000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-1887000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2820000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,532000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,860000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,860000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,12017000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,42393000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,55485000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,37082000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,45862000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,45862000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,30384000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-4696000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-20392000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,51158000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,51158000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-24676000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-296000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-137825000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,63000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,110391000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-3470000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-55813000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-55813000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-278000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-498000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2573000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,259000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2056000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2056000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,3326000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,727000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,12790000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,19320000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-118822000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-118822000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,0.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,200318000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,0.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,81496000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,81496000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-35655000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,3000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-122971000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,57000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,135963000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-149840000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-172443000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-172443000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-4089000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1218000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1138000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1733000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1733000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-4117000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-96797000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,-102945000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-106779000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,30944000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,30944000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,31096000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-2042000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-24738000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,35260000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,35260000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-34654000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-245000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-186878000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,0.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,150821000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-15329000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-86285000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-86285000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-225000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,139000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3464000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,341000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3719000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3719000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,6887000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-40419000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,12340000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,25010000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,48565000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,48565000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,31653000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-1764000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4812000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,73642000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,73642000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-41043000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-988000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-215930000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,114000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,110554000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-3260000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-150553000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-150553000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-142000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-101000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,87000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2748000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,208000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2800000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2800000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-3214000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-77325000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,11761000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,22609000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,42371000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,42371000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,32136000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-9952000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,6787000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,71342000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,71342000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-36669000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-491000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-146139000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,117000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,99146000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-19890000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-103926000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-103926000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-342000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-226000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2746000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,376000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2554000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2554000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-30030000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,11828000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,26165000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-121880000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-121880000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,0.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,208116000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,0.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,86236000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,86236000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-30503000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-56000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-171462000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,6094000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,97826000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,38479000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-59622000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-59622000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-102000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1653000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1964000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3515000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3515000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,6802000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,36931000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,-35929000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-167481000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,19520000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,19520000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,33290000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-1468000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-30842000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,20500000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,20500000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-34103000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-463000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-146971000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,26000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,141228000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-75056000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-115339000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-115339000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-93000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,0.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3135000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,106000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3148000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3148000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-3068000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-94759000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,11675000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,14195000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-19520000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-19520000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,0.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,42774000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,0.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,23254000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,23254000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-24495000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-37000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-195747000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,1062000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,124934000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,75056000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-19227000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-19227000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-48000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3445000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-12681000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-9284000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-9284000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,3627000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1630000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,-11675000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-56297000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,54832000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-20340000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-50828000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,164000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,245934000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3,2013-07-01,2013-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,174930000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,174930000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-300055000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2817000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-12091000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-309329000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-309329000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,4361000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3,2013-07-01,2013-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-75206000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3,2013-07-01,2013-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,101822000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,76890000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-34060000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-200000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,6832000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,-38000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,53735000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-72054000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q4,2013-10-01,2013-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-45785000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-45785000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-32000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,48000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1840000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1912000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3768000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3768000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,4885000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q4,2013-10-01,2013-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,39758000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q4,2013-10-01,2013-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,-61233000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q4,2013-10-01,2013-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-130864000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:33:51+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,65570000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:33:51+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-23945000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:33:51+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-12358000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:33:51+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-45273000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:33:51+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,114000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:33:51+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,45892000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:33:51+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-35570000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:33:51+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-35570000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:33:51+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-116000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:33:51+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3424000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:33:51+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,182000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:33:51+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3490000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:33:51+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3490000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:33:51+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-534000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:33:51+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,32956000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:33:51+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,292000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:33:51+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,6909000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,76872000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-71575000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-3024000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-53800000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,224000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,69189000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2,2014-04-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-58986000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-58986000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-527000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3049000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,286000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2808000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2808000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-531000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2,2014-04-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,20163000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2,2014-04-01,2014-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,10620000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2,2014-04-01,2014-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,10150000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,90654000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-28990000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-106000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-60534000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,43000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,43076000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-46511000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-46511000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-424000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1892000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,298000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1766000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1766000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-5986000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,39923000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3,2014-07-01,2014-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,-155000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3,2014-07-01,2014-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,14046000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,40204000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-41116000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,9000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-46139000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,-156000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,37958000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q4,2014-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-49444000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-49444000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1270000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,6686000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-1791000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3625000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3625000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-5739000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q4,2014-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-11342000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q4,2014-10-01,2014-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,-10757000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q4,2014-10-01,2014-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-60044000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:06:29+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,29446000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:06:29+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-27975000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:06:29+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1307000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:06:29+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-66568000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:06:29+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,4000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:06:29+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,67855000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:06:29+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-27991000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:06:29+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-27991000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:06:29+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-66000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:06:29+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1506000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:06:29+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-1771000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:06:29+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-331000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:06:29+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-331000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:06:29+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,11353000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:06:29+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,12477000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:06:29+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,-471000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:06:29+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-1503000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,38533000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-33883000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-14000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-44724000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,25000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,50731000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-27865000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-27865000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-65000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3080000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,46000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3061000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3061000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,10676000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,24405000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2,2015-04-01,2015-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,9542000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2,2015-04-01,2015-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,7772000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,82279000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-25645000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-54000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-61148000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,12000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,59600000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-27235000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-27235000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-75000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,74000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,140000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1984000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2123000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2123000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,29000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,57196000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3,2015-07-01,2015-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,549000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3,2015-07-01,2015-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,9377000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,35942000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-28853000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,3000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-126267000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,38000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,71301000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q4,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-83778000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-83778000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-76000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-74000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3510000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,368000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3728000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3728000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-5682000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q4,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-49780000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q4,2015-10-01,2015-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,-9620000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q4,2015-10-01,2015-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-47361000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,12276000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,12276000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,34090000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4807000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-58621000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-7448000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-7448000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-34930000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-71485000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,1000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,55556000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-50858000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-50858000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-77000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3768000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-3433000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,258000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,258000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,4114000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-53934000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,187000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-10421000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,18014000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,18014000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,37578000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4459000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,17104000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,77155000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,77155000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-33418000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-76938000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,20000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,50866000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-59470000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-59470000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-79000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3107000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,8000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3036000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3036000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-5685000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,15036000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,10724000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,21506000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,18405000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,18405000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,38488000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4033000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-9319000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,51607000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,51607000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-39766000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-69397000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,357000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,55377000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-53429000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-53429000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-75000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1953000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1019000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2897000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2897000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1787000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-712000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,284000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,26288000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:00:09+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-56200000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:00:09+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-112873000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:00:09+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-68305000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:00:09+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,15000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:00:09+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,70771000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:00:09+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-110392000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:00:09+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-110392000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:00:09+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-112000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:00:09+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3890000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:00:09+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-3105000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:00:09+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,673000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:00:09+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,673000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:00:09+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,1338000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:00:09+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-164581000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:00:09+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,54000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:00:09+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-8804000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,62500000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-29571000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-74688000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,6000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,66970000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2,2017-04-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-37283000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-37283000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-73000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-883000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-112000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1068000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1068000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,5852000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2,2017-04-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,30001000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2,2017-04-01,2017-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,-10919000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2,2017-04-01,2017-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-10262000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,28500000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-21484000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-90773000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,41000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,97402000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3,2017-07-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-14814000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-14814000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-71000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-2037000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-156000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-576000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2840000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2840000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-3367000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3,2017-07-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,7479000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3,2017-07-01,2017-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,10865000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3,2017-07-01,2017-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-20755000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,69337000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,48801000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-126535000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,24000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,64627000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q4,2017-10-01,2017-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-13083000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-13083000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-96000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,10982000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-7310000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3576000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3576000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-4917000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q4,2017-10-01,2017-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,54913000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q4,2017-10-01,2017-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,-22224000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q4,2017-10-01,2017-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-12315000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:08:23+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,40346000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:08:23+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-27187000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:08:23+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-61443000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:08:23+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,6937000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:08:23+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,62877000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:08:23+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,0.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:08:23+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-18816000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:08:23+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-18816000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:08:23+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-87000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:08:23+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3872000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:08:23+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-1270000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:08:23+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2515000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:08:23+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2515000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:08:23+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1383000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:08:23+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,22662000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:08:23+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,-378000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:08:23+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-3245000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,77862000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-26713000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-121558000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,4082000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,60081000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,266000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2,2018-04-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-83842000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-83842000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1418000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3240000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-3838000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2016000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2016000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,4436000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2,2018-04-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-3560000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2,2018-04-01,2018-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,-10899000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2,2018-04-01,2018-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-44375000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,62277000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-22054000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-103825000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,218000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,96152000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3,2018-07-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-29509000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-29509000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-90000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3746000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-5832000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2176000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2176000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,912000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3,2018-07-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,31504000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3,2018-07-01,2018-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,-444000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3,2018-07-01,2018-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-10220000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,105009000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-53874000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-84193000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,42000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,83480000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-266000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q4,2018-10-01,2018-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-54811000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-54811000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1366000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-48912000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3275000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-47003000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-47003000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-4620000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q4,2018-10-01,2018-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1425000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q4,2018-10-01,2018-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,-10982000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q4,2018-10-01,2018-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-4574000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:55:32+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,42943000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:55:32+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-23629000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:55:32+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-16083000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:55:32+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-95375000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:55:32+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,74000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:55:32+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,104897000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:55:32+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,7403000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:55:32+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-22713000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:55:32+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-22713000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:55:32+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-237000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:55:32+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,0.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:55:32+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3831000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:55:32+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-1433000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:55:32+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2161000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:55:32+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2161000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:55:32+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,1982000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:55:32+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,24373000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:55:32+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,-459000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:55:32+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-4567000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,155402000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-22214000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,16083000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-76240000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,7395000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,83391000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-23486000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2,2019-04-01,2019-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-15071000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-15071000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-580000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-15001000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3912000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-3976000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-15645000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-15645000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,145000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2,2019-04-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,124831000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2,2019-04-01,2019-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,-10626000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2,2019-04-01,2019-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-19449000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,99750000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-31091000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-95224000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,-1000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,76135000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-59728000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3,2019-07-01,2019-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-109909000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-109909000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-156000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-4999000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,5828000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-5164000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-4491000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-4491000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-5366000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3,2019-07-01,2019-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-20016000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3,2019-07-01,2019-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,-296000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3,2019-07-01,2019-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-18618000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,159802000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-21598000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-183997000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,1479000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,67109000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,75811000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q4,2019-10-01,2019-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-61196000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-61196000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-156000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-8000000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3373000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-4783000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-4783000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,5476000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q4,2019-10-01,2019-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,99299000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q4,2019-10-01,2019-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,-10949000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q4,2019-10-01,2019-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-2447000.0
